Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.

MeSH Terms: Acquired Immunodeficiency Syndrome, Cholesterol, HIV Protease Inhibitors, Humans, Nelfinavir, Randomized Controlled Trials as Topic